Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Health Catalyst Inc

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Health Catalyst (HCAT) and Medicus Pharma Ltd (MDCX)...

Analysts Are Bullish on Top Healthcare Stocks: Health Catalyst (HCAT), Medicus Pharma Ltd (MDCX)

Health Catalyst ( ($HCAT) ) just unveiled an update. On June 4, 2026, Health Catalyst agreed to sell all equity interests in Vitalware, its mid-rev...

Health Catalyst Divests Vitalware to Strengthen Core Focus

In a report released today, David Grossman from Stifel Nicolaus maintained a Hold rating on Health Catalyst, with a price target of $2.00. Grossman...

Health Catalyst (HCAT) Gets a Hold from Stifel Nicolaus

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dyne Therapeutics (DYN), Health Catalyst (HCAT) an...

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), Health Catalyst (HCAT) and Gain Therapeutics (GANX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Health Catalyst (HCAT) and Fisher & Paykel Healthcare Corporation...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HCAT	$1.93	-0.52%	4.62M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HCAT	$1.93	-0.5%	4.62M
3
4
5
6

HCAT

HCAT

Get Health Catalyst Inc Data in Excel

Get Health Catalyst Inc Data in Excel